Harlan C. Amstutz, M.D., receives Lifetime Achievement Award
Nov 1, 2018 | St. Vincent News, Featured Employees
In October, Harlan C. Amstutz, MD, was awarded the Lifetime Achievement Award presented by The International Society for Technology in Arthroplasty (ISTA) which is a nonprofit corporation that brings awareness and research to arthroplasty – the surgical reconstruction or replacement of a joint.
“This award is special because it was unexpected,” said Dr. Amstutz. “ I’ve been a participant in many ISTA events over the years and have always been impressed by the quality of the participants and the programs. It is an honor to receive such a prestigious award from such an impressive society.”
Every year, ISTA’s Board of Directors proposes a list of candidates and votes on who should be the recipient of the Lifetime Achievement Award. Candidates are chosen based on a career significantly devoted to joint arthroplasty; collaborations with clinicians, researchers, and industry; and having an impact on arthroplasty around the world.
Dr. Amstutz is the founding director of the Joint Replacement Institute and has been with St. Vincent Medical Center for 12 years. He graduated from UCLA and was the Chief of Orthopaedics for the US Air Force from 1961-1963. In addition, he was a Professor and Chief of Orthopaedics at UCLA Medical Center from 1970 through 1989. In the United States, Dr. Amstutz is considered the father of hip resurfacing since he was one of five surgeons around the world who had the same concept of hip resurfacing at the same time.
Thomas Schmalzried, MD, orthopedic surgeon, said, “Dr. Amstutz was an arthroplasty pioneer, a technology innovator, a mentor, and a dedicated physician and surgeon. He is most deserving of a Lifetime Achievement Award from ISTA.”
To name just a few, Dr. Amstutz’s achievements include 675 national and international presentations; 65 Visiting Professorships and named Lectureships; Member of 27 national and international societies; major research in areas of bioengineering, biomechanics and biomaterials; developer of several of the most successful total hip replacement devices since 1970; innovator and developer of the Conserve® Hemisurface and Conserve® Plus hip surface arthroplasty utilizing metal-metal bearing technology; author or co-author of over 500 scientific publications and abstracts; and has served as Chairman of the Gordon Conference of Biomaterials, President of the North American Hip Society, President of the Orthopaedic Research Society, President of the Association of Bone and Joint Surgeons, President of the Association of Orthopaedic Chairman, President of the American Orthopaedic Association and President of the International Hip Society. A publication on long-term results on metal-metal hip resurfacing will be coming out soon in Bone & Joint Journal while two other pending publications will be in Hip International.
On top of all his accomplishments, Dr. Amstutz received the UCLA Chemistry and Biochemistry 2018 Alumni Award and was the commencement speaker for the UCLA graduation in June for chemistry. He tells the graduating class, “You’ve had the pleasure of completing a task at one of the world’s greatest universities. And oh, by the way, please occasionally turn off those wonderfully addicting electronic devices. Look up, make eye contact, listen to the birds sing and smell the flowers.” Watch the full commencement address by clicking here.